Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Macimorelin.

Research draft

Macimorelin is an oral ghrelin-receptor agonist used in growth-hormone diagnostic testing.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Macimorelin is an oral ghrelin-receptor agonist used in growth-hormone diagnostic testing.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It stimulates GH release to assess the pituitary response.

Human research

Clinical diagnostic evidence concerns adult GH deficiency; this is not therapeutic hormone replacement.

Preclinical & other research

Pharmacology studies characterised the stimulation response.

Safety & unknowns

QT-related warnings and medicine interactions require the approved label.

Regulatory status

US Macrilen is a regulated diagnostic product; paediatric studies do not automatically extend its indication.

Reported use & evidence

Research profile draft

The supplied Macimorelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds